Oak Longevity vs Enhance MD: Pricing, Process, and Features
Quick verdict: Oak Longevity focuses on lowest ongoing prices with no subscriptions and free coaching, while Enhance MD emphasizes very low first-month pricing and flat-rate pricing that stays the same at every dose.
Explore Oak Longevity pricing and plans
Oak Longevity vs Enhance MD: head-to-head overview
The phrase Oak Longevity vs Enhance MD compares two telehealth platforms that both sell compounded GLP-1s, but they differ most notably on starting price structure, ongoing pricing and dosing policies, clinical access and intake, and included services like coaching and testing. Oak Longevity markets semaglutide starting at $133/month and tirzepatide starting at $199/month with one flat price for all dosages and no subscriptions. Enhance MD advertises semaglutide from $49 the first month and tirzepatide from $99 the first month, with a flat-rate ongoing model that stays the same at every dose.
Key differences to weigh
1) First-month versus ongoing price
Enhance MD supports very low first-month entry pricing: semaglutide from $49 and tirzepatide from $99 for the first month. Oak Longevity lists semaglutide from $133/month and tirzepatide from $199/month as its starting published prices. Enhance MD notes the $49 and $99 rates are introductory first-month prices and that ongoing flat-rate pricing applies afterward. Oak advertises its semaglutide and tirzepatide prices as ongoing monthly figures and emphasizes a one-price model covering all dosages.
2) How price changes with dose
Both providers say their pricing covers all dosages in some form. Oak Longevity states one flat price covers all dosages with no tier-based pricing and no subscriptions. Enhance MD highlights flat-rate pricing that stays the same at every dose, meaning once the ongoing rate is set it does not escalate with higher doses after titration. Enhance MD calls out that some competitors increase fees during titration and positions its flat-rate approach as a hedge against surprise increases.
3) Intake, clinical review, and added services
Oak Longevity performs an asynchronous clinical review and does not require a video call or insurance, includes free health coaching and free shipping with tracking, and says board-certified physicians in your state review every case. Enhance MD frames its offering as clinician-directed compounds with metabolic lab testing every six months and positions itself as a premium metabolic care program. Both note clinician review determines appropriateness of treatment.
4) Regulatory and product type disclaimers
Both sites state their medications are compounded and note compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness, or quality. Oak specifies patients with BMI below 20 or 22 do not qualify in certain circumstances and that treatment is available only when a licensed clinician determines it is medically appropriate. Enhance MD also notes treatment is available only when a licensed clinician determines it is medically appropriate.
| Criteria | Oak Longevity | Enhance MD |
|---|---|---|
| Semaglutide starting price | Semaglutide from $133/month | Semaglutide from $49 first month |
| Tirzepatide starting price | Tirzepatide from $199/month | Tirzepatide from $99 first month |
| Price model | One flat price covers all dosages, no subscriptions | Introductory low first month; ongoing flat-rate pricing that stays the same at every dose |
| Clinical intake | Asynchronous review, no video call required; board-certified physicians review cases | Clinician-directed review; metabolic lab testing every 6 months |
| Included services | Free health coaching and free shipping with tracking | Metabolic lab testing every 6 months; first-month promotions available |
| Regulatory note | Compounded medications are not FDA-approved finished products | Compounded medications are not FDA-approved finished products |
Practical implications for patients
If your priority is the lowest possible entry cost for the first month or you want to evaluate both compounds on a low-cost initial trial, Enhance MD provides semaglutide from $49 and tirzepatide from $99 for the first month and emphasizes flat-rate ongoing pricing that eliminates dose escalation fees. If you prefer a clearly published ongoing monthly price with included coaching and free shipping and want to avoid subscriptions or membership fees, Oak Longevity publishes semaglutide from $133/month and tirzepatide from $199/month and highlights no subscriptions and one flat price for all dosages.
See Enhance MD first-month pricing
View Oak Longevity plans and coaching
Safety, limits, and what is not supplied
Both providers make the regulatory point that their compounded medications are not FDA-approved finished products. Oak Longevity states patients under 18, pregnant, or nursing are not appropriate candidates and that results vary by individual. Enhance MD notes the $49 and $99 rates are first-month offers and that ongoing pricing applies thereafter. If you need information on state availability, insurance coverage, or detailed ongoing price tables for every plan and state, that specific granular data is not supplied here.
Compare Enhance MD offers and details
Start with Oak Longevity pricing and eligibility
Conclusion: Oak Longevity vs Enhance MD
Oak Longevity vs Enhance MD comes down to whether you value lower published ongoing prices plus free coaching and shipping, or the lowest possible first-month entry and a flat-rate policy that avoids dose escalation. Both sell compounded semaglutide and tirzepatide and require clinician review. Oak Longevity lists semaglutide from $133/month and tirzepatide from $199/month, with no subscriptions and free coaching. Enhance MD offers semaglutide from $49 the first month and tirzepatide from $99 the first month and uses a flat-rate pricing model that stays the same at every dose.
Choose Oak Longevity if you want clearly published ongoing monthly prices, included free health coaching and free shipping, no subscription model, and asynchronous clinical review. Choose Enhance MD if you want the lowest first-month entry prices and a flat-rate ongoing approach that avoids dose escalation surprises.